{"id":15592,"date":"2023-03-08T09:43:00","date_gmt":"2023-03-08T09:43:00","guid":{"rendered":"http:\/\/model1.caplinpoint.net\/?p=15592"},"modified":"2023-12-09T09:50:42","modified_gmt":"2023-12-09T09:50:42","slug":"caplin-steriles-gets-usfda-approval-for-thiamine-hydrochloride-injection","status":"publish","type":"post","link":"http:\/\/model1.caplinpoint.net\/index.php\/2023\/03\/08\/caplin-steriles-gets-usfda-approval-for-thiamine-hydrochloride-injection\/","title":{"rendered":"CAPLIN STERILES GETS USFDA APPROVAL FOR THIAMINE HYDROCHLORIDE INJECTION"},"content":{"rendered":"\n<p>Chennai, March 08, 2023: Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Thiamine Hydrochloride Injection USP, 200 mg\/2 mL (100 mg\/mL) Multi-dose Vial, a generic therapeutic equivalent version of (RLD), THIAMINE HYDROCHLORIDE injection of Fresenius Kabi USA LLC<\/p>\n\n\n\n<p>Thiamine Hydrochloride Injection is effective in the treatment of Thiamine (Vitamin B1) deficiency or beriberi, a serious condition caused by prolonged lack of Vitamin B1. According to IQVIATM (IMS Health), Thiamine Hydrochloride Injection had US sales of approximately $38 million for the 12-month period ending September 2022.<\/p>\n\n\n\n<p>Mr. C. C. Paarthipan, Chairman of Caplin Point Laboratories Limited commented <em>&#8220;We&#8217;re glad to receive 3 back to back ANDA approvals recently, taking the tally to 16 approvals for Caplin Steriles and 4 more with partners. These recent approvals will not only help the company\u2019s current targets, but also the future.&#8221;<\/em><\/p>\n\n\n\n<div class=\"wp-block-file\"><a target=\"_blank\" href=\"http:\/\/model1.caplinpoint.net\/wp-content\/uploads\/2022\/04\/PressReleaseSEIntimationThiamineHCIInjfinal.pdf\" class=\"wp-block-file__button\" rel=\"noopener\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Chennai, March 08, 2023: Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Thiamine Hydrochloride Injection USP, 200 mg\/2 mL (100 mg\/mL) Multi-dose Vial, a generic&#8230; <\/p>\n","protected":false},"author":1,"featured_media":1229,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/15592"}],"collection":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/comments?post=15592"}],"version-history":[{"count":2,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/15592\/revisions"}],"predecessor-version":[{"id":15596,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/15592\/revisions\/15596"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media\/1229"}],"wp:attachment":[{"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media?parent=15592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/categories?post=15592"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/model1.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/tags?post=15592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}